Literature DB >> 26776511

let-7 Modulates Chromatin Configuration and Target Gene Repression through Regulation of the ARID3B Complex.

Tsai-Tsen Liao1, Wen-Hao Hsu1, Chien-Hsin Ho1, Wei-Lun Hwang2, Hsin-Yi Lan1, Ting Lo1, Cheng-Chi Chang3, Shyh-Kuan Tai4, Muh-Hwa Yang5.   

Abstract

Let-7 is crucial for both stem cell differentiation and tumor suppression. Here, we demonstrate a chromatin-dependent mechanism of let-7 in regulating target gene expression in cancer cells. Let-7 directly represses the expression of AT-rich interacting domain 3B (ARID3B), ARID3A, and importin-9. In the absence of let-7, importin-9 facilitates the nuclear import of ARID3A, which then forms a complex with ARID3B. The nuclear ARID3B complex recruits histone demethylase 4C to reduce histone 3 lysine 9 trimethylation and promotes the transcription of stemness factors. Functionally, expression of ARID3B is critical for the tumor initiation in let-7-depleted cancer cells. An inverse association between let-7 and ARID3A/ARID3B and prognostic significance is demonstrated in head and neck cancer patients. These results highlight a chromatin-dependent mechanism where let-7 regulates cancer stemness through ARID3B.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26776511     DOI: 10.1016/j.celrep.2015.12.064

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  21 in total

1.  The extracellular domain of epithelial cell adhesion molecule (EpCAM) enhances multipotency of mesenchymal stem cells through EGFR-LIN28-LET7 signaling.

Authors:  I-I Kuan; Chi-Chiu Lee; Chien-Hsu Chen; Jean Lu; Yuan-Sung Kuo; Han-Chung Wu
Journal:  J Biol Chem       Date:  2019-03-29       Impact factor: 5.157

2.  ARID3A and ARID3B induce stem promoting pathways in ovarian cancer cells.

Authors:  Paige Dausinas; Kirthi Pulakanti; Sridhar Rao; Jennifer M Cole; Richard Dahl; Karen D Cowden Dahl
Journal:  Gene       Date:  2020-02-13       Impact factor: 3.688

3.  mirDIP 4.1-integrative database of human microRNA target predictions.

Authors:  Tomas Tokar; Chiara Pastrello; Andrea E M Rossos; Mark Abovsky; Anne-Christin Hauschild; Mike Tsay; Richard Lu; Igor Jurisica
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

4.  Bioengineered miRNA-1291 prodrug therapy in pancreatic cancer cells and patient-derived xenograft mouse models.

Authors:  Mei-Juan Tu; Pui Yan Ho; Qian-Yu Zhang; Chao Jian; Jing-Xin Qiu; Edward J Kim; Richard J Bold; Frank J Gonzalez; Huichang Bi; Ai-Ming Yu
Journal:  Cancer Lett       Date:  2018-10-30       Impact factor: 8.679

5.  LIN28-let-7 axis regulates genes in immortalized human trophoblast cells by targeting the ARID3B-complex.

Authors:  Asghar Ali; Russell V Anthony; Gerrit J Bouma; Quinton A Winger
Journal:  FASEB J       Date:  2019-08-15       Impact factor: 5.834

6.  MORC2B is essential for meiotic progression and fertility.

Authors:  Baolu Shi; Jiangyang Xue; Jian Zhou; Seth D Kasowitz; Yuanwei Zhang; Guanxiang Liang; Yongjuan Guan; Qinghua Shi; Mingxi Liu; Jiahao Sha; Xiaoyan Huang; P Jeremy Wang
Journal:  PLoS Genet       Date:  2018-01-12       Impact factor: 5.917

Review 7.  Revisiting epithelial-mesenchymal transition in cancer metastasis: the connection between epithelial plasticity and stemness.

Authors:  Tsai-Tsen Liao; Muh-Hwa Yang
Journal:  Mol Oncol       Date:  2017-06-26       Impact factor: 6.603

8.  CD133 Promotes Adhesion to the Ovarian Cancer Metastatic Niche.

Authors:  Lynn Roy; Alexander Bobbs; Rachel Sattler; Jeffrey L Kurkewich; Paige B Dausinas; Prakash Nallathamby; Karen D Cowden Dahl
Journal:  Cancer Growth Metastasis       Date:  2018-04-09

9.  Characterization of brain tumor initiating cells isolated from an animal model of CNS primitive neuroectodermal tumors.

Authors:  Sergey Malchenko; Simone T Sredni; Jerusha Boyineni; Yingtao Bi; Naira V Margaryan; Maheedhara R Guda; Yulia Kostenko; Tadanori Tomita; Ramana V Davuluri; Kiran Velpula; Mary J C Hendrix; Marcelo B Soares
Journal:  Oncotarget       Date:  2018-02-09

10.  miR-31 targets ARID1A and enhances the oncogenicity and stemness of head and neck squamous cell carcinoma.

Authors:  Wen-Cheng Lu; Chung-Ji Liu; Hsi-Feng Tu; Yu-Tung Chung; Cheng-Chieh Yang; Shou-Yen Kao; Kuo-Wei Chang; Shu-Chun Lin
Journal:  Oncotarget       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.